TY - JOUR
T1 - Variation in survival of patients with lung cancer in Europe, 1985-1989
AU - Janssen-Heijnen, M. L G
AU - Gatta, G.
AU - Forman, D.
AU - Capocaccia, R.
AU - Coebergh, J. W W
PY - 1998/12
Y1 - 1998/12
N2 - In this study, we report on the variation in the prognosis for adult patients with lung cancer within Europe, by age, histology and country from 1985-1989. We considered trends in survival since 1978 for most countries. Survival analysis was carried out on 173448 lung cancer eases diagnosed between 1985 and 1989 in 44 population-based cancer registries, participating in the EUROCARE study. Relative 1-year survival rates for patients with lung cancer varied from 24 to 40%, being highest in Finland, France, The Netherlands and Switzerland and lowest in Denmark, England, Poland and Scotland. Half of all patients under the age of 45 years died within 1 year of diagnosis, increasing to almost 80% for those aged 75 years or older. Whilst the prognosis for patients with non-small cell carcinoma remained more or less constant between 1978 and 1989 (25% in Denmark and 44% in Finland), that for patients with small cell careinoma improved slightly, especially in The Netherlands (Eindhoven from 17 to 24%) and Switzerland (Geneva from 24 to 32%). In conclusion, a fairly large variation in lung cancer relative survival rates existed between European countries. The most likely explanation for the differences is the variation in access to specialized care. Except for a slight improvement in short-term survival for patients with small cell lung cancer, survival has remained poor since 1978.
AB - In this study, we report on the variation in the prognosis for adult patients with lung cancer within Europe, by age, histology and country from 1985-1989. We considered trends in survival since 1978 for most countries. Survival analysis was carried out on 173448 lung cancer eases diagnosed between 1985 and 1989 in 44 population-based cancer registries, participating in the EUROCARE study. Relative 1-year survival rates for patients with lung cancer varied from 24 to 40%, being highest in Finland, France, The Netherlands and Switzerland and lowest in Denmark, England, Poland and Scotland. Half of all patients under the age of 45 years died within 1 year of diagnosis, increasing to almost 80% for those aged 75 years or older. Whilst the prognosis for patients with non-small cell carcinoma remained more or less constant between 1978 and 1989 (25% in Denmark and 44% in Finland), that for patients with small cell careinoma improved slightly, especially in The Netherlands (Eindhoven from 17 to 24%) and Switzerland (Geneva from 24 to 32%). In conclusion, a fairly large variation in lung cancer relative survival rates existed between European countries. The most likely explanation for the differences is the variation in access to specialized care. Except for a slight improvement in short-term survival for patients with small cell lung cancer, survival has remained poor since 1978.
KW - Europe
KW - Histology
KW - Lung cancer
KW - Survival
KW - Trends
UR - http://www.scopus.com/inward/record.url?scp=0032430677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032430677&partnerID=8YFLogxK
U2 - 10.1016/S0959-8049(98)00312-8
DO - 10.1016/S0959-8049(98)00312-8
M3 - Article
C2 - 10070286
VL - 34
SP - 2191
EP - 2196
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0959-8049
IS - 14
ER -